<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36552734</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3972</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11243972</ELocationID><Abstract><AbstractText>Non-receptor tyrosine kinase, c-Abl plays a role in the pathogenesis of several neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Here, we found that TDP-43, which was one of the main proteins comprising pathological deposits in amyotrophic lateral sclerosis (ALS), is a novel substrate for c-Abl. The phosphorylation of tyrosine 43 of TDP-43 by c-Abl led to increased TDP-43 levels in the cytoplasm and increased the formation of G3BP1-positive stress granules in SH-SY5Y cells. The kinase-dead mutant of c-Abl had no effect on the cytoplasmic localization of TDP-43. The expression of phosphor-mimetic mutant Y43E of TDP-43 in primary cortical neurons accumulated the neurite granule. Furthermore, the phosphorylation of TDP-43 at tyrosine 43 by c-Abl promoted the aggregation of TDP-43 and increased neuronal cell death in primary cortical neurons, but not in c-Abl-deficient primary cortical neurons. Identification of c-Abl as the kinase of TDP43 provides new insight into the pathogenesis of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Saebom</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Hye Guk</ForeName><Initials>HG</Initials><Identifier Source="ORCID">0000-0002-5901-1316</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju 28644, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cosmetic Science and Technology, Daegu Haany University, Gyeongsan 38610, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kweon</LastName><ForeName>Sin Ho</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyerynn</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju 28644, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hyeonwoo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju 28644, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kyung-Ha</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Cosmetic Science and Technology, Daegu Haany University, Gyeongsan 38610, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Biology, Pusan National University, Busan 46241, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Sang-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Chungbuk National University, Cheongju 28644, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Chan Hyun</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sangjune</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3052-3163</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju 28644, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Han Seok</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0002-0864-5239</Identifier><AffiliationInfo><Affiliation>Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01NS107404</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="C116070">G3BP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075223">Poly-ADP-Ribose Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067776">RNA Recognition Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D016315">Proto-Oncogene Proteins c-abl</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>42HK56048U</RegistryNumber><NameOfSubstance UI="D014443">Tyrosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="N">Neuroblastoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075223" MajorTopicYN="N">Poly-ADP-Ribose Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067776" MajorTopicYN="N">RNA Recognition Motif Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016315" MajorTopicYN="Y">Proto-Oncogene Proteins c-abl</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014443" MajorTopicYN="N">Tyrosine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">c-Abl</Keyword><Keyword MajorTopicYN="N">mislocalization</Keyword><Keyword MajorTopicYN="N">phosphorylation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36552734</ArticleId><ArticleId IdType="pmc">PMC9776721</ArticleId><ArticleId IdType="doi">10.3390/cells11243972</ArticleId><ArticleId IdType="pii">cells11243972</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q., Lee V.M. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008;283:13302&#x2013;13309. doi: 10.1074/jbc.M800342200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Brindisi A., Giombi M., Tisminetzky S., Ayala Y.M., Baralle F.E. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 2005;280:37572&#x2013;37584. doi: 10.1074/jbc.M505557200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505557200</ArticleId><ArticleId IdType="pubmed">16157593</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk T.R., Rousseaux M.W.C. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol. Neurodegener. 2020;15:45. doi: 10.1186/s13024-020-00397-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00397-1</ArticleId><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L.M., Kwong L.K., Xu Y., Truax A.C., Uryu K., Neumann M., Clark C.M., Elman L.B., Miller B.L., Grossman M., et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 2008;173:182&#x2013;194. doi: 10.2353/ajpath.2008.080003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080003</ArticleId><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A., Caron G., Gkogkas C.G., Mohamed N.V., Destroismaisons L., Sonenberg N., Leclerc N., Parker J.A., Vande Velde C. G3BP1 promotes stress-induced RNA granule interactions to preserve polyadenylated mRNA. J. Cell. Biol. 2015;209:73&#x2013;84. doi: 10.1083/jcb.201408092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201408092</ArticleId><ArticleId IdType="pmc">PMC4395486</ArticleId><ArticleId IdType="pubmed">25847539</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. TDP-43 post-translational modifications in health and disease. Expert Opin. Ther. Targets. 2018;22:279&#x2013;293. doi: 10.1080/14728222.2018.1439923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2018.1439923</ArticleId><ArticleId IdType="pubmed">29431050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008;64:60&#x2013;70. doi: 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Choksi D.K., Roy B., Chatterjee S., Yusuff T., Bakhoum M.F., Sengupta U., Ambegaokar S., Kayed R., Jackson G.R. TDP-43 Phosphorylation by casein kinase Iepsilon promotes oligomerization and enhances toxicity in vivo. Hum. Mol. Genet. 2014;23:1025&#x2013;1035. doi: 10.1093/hmg/ddt498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt498</ArticleId><ArticleId IdType="pubmed">24105464</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Vandoorne T., Steyaert J., Staats K.A., Van Den Bosch L. The multifaceted role of kinases in amyotrophic lateral sclerosis: Genetic, pathological and therapeutic implications. Brain. 2020;143:1651&#x2013;1673. doi: 10.1093/brain/awaa022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa022</ArticleId><ArticleId IdType="pmc">PMC7296858</ArticleId><ArticleId IdType="pubmed">32206784</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2005;57:236&#x2013;251. doi: 10.1002/ana.20379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20379</ArticleId><ArticleId IdType="pubmed">15668976</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K., Izumi Y., Watanabe A., Tsukita K., Woltjen K., Yamamoto T., Hotta A., Kondo T., Kitaoka S., Ohta A., et al. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:eaaf3962. doi: 10.1126/scitranslmed.aaf3962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf3962</ArticleId><ArticleId IdType="pubmed">28539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsumata R., Ishigaki S., Katsuno M., Kawai K., Sone J., Huang Z., Adachi H., Tanaka F., Urano F., Sobue G. c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e46185. doi: 10.1371/journal.pone.0046185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046185</ArticleId><ArticleId IdType="pmc">PMC3458026</ArticleId><ArticleId IdType="pubmed">23049975</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenqiang C., Lonskaya I., Hebron M.L., Ibrahim Z., Olszewski R.T., Neale J.H., Moussa C.E. Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice. Hum. Mol. Genet. 2014;23:4960&#x2013;4969. doi: 10.1093/hmg/ddu211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu211</ArticleId><ArticleId IdType="pubmed">24847002</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmachari S., Lee S., Kim S., Yuan C., Karuppagounder S.S., Ge P., Shi R., Kim E.J., Liu A., Kim D., et al. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson&#x2019;s disease. Brain. 2019;142:2380&#x2013;2401. doi: 10.1093/brain/awz172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz172</ArticleId><ArticleId IdType="pmc">PMC6658849</ArticleId><ArticleId IdType="pubmed">31237944</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pluckthun A., Mittl P., et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017;8:45. doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Horio T., Hamasaki T., Inoue T., Wakayama T., Itou S., Naito H., Asaki T., Hayase H., Niwa T. Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives. Bioorg. Med. Chem. Lett. 2007;17:2712&#x2013;2717. doi: 10.1016/j.bmcl.2007.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2007.03.002</ArticleId><ArticleId IdType="pubmed">17376680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran K.V., Fu J.M., Schaffer T.B., Na C.H., Delannoy M., Margolis S.S. Activity-Dependent Degradation of the Nascentome by the Neuronal Membrane Proteasome. Mol. Cell. 2018;71:169&#x2013;177 e166. doi: 10.1016/j.molcel.2018.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.06.013</ArticleId><ArticleId IdType="pmc">PMC6070390</ArticleId><ArticleId IdType="pubmed">29979964</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S.Y., Ali M., Kabir F., Renuse S., Na C.H., Talbot C.C., Jr., Hackett S.F., Riazuddin S.A. Proteome Profiling of Developing Murine Lens Through Mass Spectrometry. Investig. Ophthalmol. Vis. Sci. 2018;59:100&#x2013;107. doi: 10.1167/iovs.17-21601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.17-21601</ArticleId><ArticleId IdType="pmc">PMC5769801</ArticleId><ArticleId IdType="pubmed">29332127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S.X., Seo B.A., Kim D., Xiong Y., Kwon S.H., Brahmachari S., Kim S., Kam T.I., Nirujogi R.S., Kwon S.H., et al. Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in alpha-Synuclein-Based Mouse Models of Parkinson&#x2019;s Disease. J. Proteome Res. 2021;20:3428&#x2013;3443. doi: 10.1021/acs.jproteome.0c01002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c01002</ArticleId><ArticleId IdType="pmc">PMC8628316</ArticleId><ArticleId IdType="pubmed">34061533</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008;26:1367&#x2013;1372. doi: 10.1038/nbt.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1511</ArticleId><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkinderen P., Scales T.M., Hanger D.P., Leung K.Y., Byers H.L., Ward M.A., Lenz C., Price C., Bird I.N., Perera T., et al. Tyrosine 394 is phosphorylated in Alzheimer&#x2019;s paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J. Neurosci. 2005;25:6584&#x2013;6593. doi: 10.1523/JNEUROSCI.1487-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1487-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725430</ArticleId><ArticleId IdType="pubmed">16014719</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahul-Mellier A.L., Fauvet B., Gysbers A., Dikiy I., Oueslati A., Georgeon S., Lamontanara A.J., Bisquertt A., Eliezer D., Masliah E., et al. c-Abl phosphorylates alpha-synuclein and regulates its degradation: Implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson&#x2019;s disease. Hum. Mol. Genet. 2014;23:2858&#x2013;2879. doi: 10.1093/hmg/ddt674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt674</ArticleId><ArticleId IdType="pmc">PMC4014189</ArticleId><ArticleId IdType="pubmed">24412932</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmachari S., Ge P., Lee S.H., Kim D., Karuppagounder S.S., Kumar M., Mao X., Shin J.H., Lee Y., Pletnikova O., et al. Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration. J. Clin. Investig. 2016;126:2970&#x2013;2988. doi: 10.1172/JCI85456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI85456</ArticleId><ArticleId IdType="pmc">PMC4966315</ArticleId><ArticleId IdType="pubmed">27348587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala Y.M., Zago P., D&#x2019;Ambrogio A., Xu Y.F., Petrucelli L., Buratti E., Baralle F.E. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008;121:3778&#x2013;3785. doi: 10.1242/jcs.038950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.B., Scotter E.L., Lee D.Y., Troakes C., Mitchell J., Rogelj B., Gallo J.M., Shaw C.E. Cytoplasmic TDP-43 is involved in cell fate during stress recovery. Hum. Mol. Genet. 2021;31:166&#x2013;175. doi: 10.1093/hmg/ddab227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab227</ArticleId><ArticleId IdType="pmc">PMC8743001</ArticleId><ArticleId IdType="pubmed">34378050</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz L.M., Kwong L.K., Chen-Plotkin A., Winton M.J., Unger T.L., Xu Y., Neumann M., Trojanowski J.Q., Lee V.M. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies. J. Biol. Chem. 2009;284:8516&#x2013;8524. doi: 10.1074/jbc.M809462200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809462200</ArticleId><ArticleId IdType="pmc">PMC2659210</ArticleId><ArticleId IdType="pubmed">19164285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharbanda S., Ren R., Pandey P., Shafman T.D., Feller S.M., Weichselbaum R.R., Kufe D.W. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature. 1995;376:785&#x2013;788. doi: 10.1038/376785a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/376785a0</ArticleId><ArticleId IdType="pubmed">7651539</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmachari S., Karuppagounder S.S., Ge P., Lee S., Dawson V.L., Dawson T.M., Ko H.S. c-Abl and Parkinson&#x2019;s Disease: Mechanisms and Therapeutic Potential. J. Parkinsons Dis. 2017;7:589&#x2013;601. doi: 10.3233/JPD-171191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-171191</ArticleId><ArticleId IdType="pmc">PMC5676866</ArticleId><ArticleId IdType="pubmed">29103051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancino G.I., Perez de Arce K., Castro P.U., Toledo E.M., von Bernhardi R., Alvarez A.R. c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice. Neurobiol. Aging. 2011;32:1249&#x2013;1261. doi: 10.1016/j.neurobiolaging.2009.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.07.007</ArticleId><ArticleId IdType="pubmed">19700222</ArticleId></ArticleIdList></Reference><Reference><Citation>Eck R.J., Kraemer B.C., Liachko N.F. Regulation of TDP-43 phosphorylation in aging and disease. Geroscience. 2021;43:1605&#x2013;1614. doi: 10.1007/s11357-021-00383-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00383-5</ArticleId><ArticleId IdType="pmc">PMC8492835</ArticleId><ArticleId IdType="pubmed">34032984</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko N.F., McMillan P.J., Guthrie C.R., Bird T.D., Leverenz J.B., Kraemer B.C. CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration. Ann. Neurol. 2013;74:39&#x2013;52. doi: 10.1002/ana.23870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23870</ArticleId><ArticleId IdType="pmc">PMC3775949</ArticleId><ArticleId IdType="pubmed">23424178</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko N.F., McMillan P.J., Strovas T.J., Loomis E., Greenup L., Murrell J.R., Ghetti B., Raskind M.A., Montine T.J., Bird T.D., et al. The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43. PLoS Genet. 2014;10:e1004803. doi: 10.1371/journal.pgen.1004803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004803</ArticleId><ArticleId IdType="pmc">PMC4256087</ArticleId><ArticleId IdType="pubmed">25473830</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano V., Quadri Z., Baralle F.E., Buratti E. The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function. Prion. 2015;9:1&#x2013;9. doi: 10.1080/19336896.2015.1011885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2015.1011885</ArticleId><ArticleId IdType="pmc">PMC4601194</ArticleId><ArticleId IdType="pubmed">25635624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.B., Lee V.M., Trojanowski J.Q. Gains or losses: Molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 2011;13:38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Hideyama T., Hachiga K., Teramoto S., Takano J., Iwata N., Saido T.C., Kwak S. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat. Commun. 2012;3:1307. doi: 10.1038/ncomms2303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2303</ArticleId><ArticleId IdType="pubmed">23250437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.J., Xu Y.F., Dickey C.A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D., Petrucelli L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 2007;27:10530&#x2013;10534. doi: 10.1523/JNEUROSCI.3421-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3421-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673167</ArticleId><ArticleId IdType="pubmed">17898224</ArticleId></ArticleIdList></Reference><Reference><Citation>Raina D., Pandey P., Ahmad R., Bharti A., Ren J., Kharbanda S., Weichselbaum R., Kufe D. c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. J. Biol. Chem. 2005;280:11147&#x2013;11151. doi: 10.1074/jbc.M413787200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M413787200</ArticleId><ArticleId IdType="pubmed">15657060</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F., Obi T., Shishido T., Akatsu H., Murayama S., Saito Y., Yoshida M., Hasegawa M. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci. Rep. 2016;6:23281. doi: 10.1038/srep23281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23281</ArticleId><ArticleId IdType="pmc">PMC4793195</ArticleId><ArticleId IdType="pubmed">26980269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>